Articles Found : 1000
Page 1 of 40 |
| 1. |
(9/13/2007 - ) |
|
 |
| 2. |
Interview with Dr. Douglas Thompson on The National Growth and Health Study
( - Douglas Thompson, PhD* )
In 1985, the National Growth and Health Study (NGHS), sponsored by the National Heart, Lung, and Blood Institute (NHLBI), was undertaken to examine racial differences in the development of obesity ... |
|
|
| 3. |
'Anti-atherogenic' diet raises Lp(a) and oxidized LDL levels.
(Monday, March 22, 2004 - Arterioscler Thromb Vasc Biol 2004; 24: 498-503)
Researchers report that consumption of a diet traditionally considered to be anti-atherogenic resulted in increased plasma levels of circulating lipoprotein and oxidized low-density lipoprotein in a g... |
|
|
| 4. |
'Apple-shaped' body riskiest for MI in elderly women
(Tuesday, November 02, 2004 - Am J Epidemiol 2004; 160: 741-749)
Intra-abdominal fat, characterized by an "apple-shaped" body, is the strongest and most independent predictor of the risk of myocardial infarction in elderly women, US scientists say. |
|
|
| 5. |
'Atypical' ACS presentation in women challenged
(Wednesday, December 12, 2007 - Arch Intern Med 2007; 167: 2405-2413)
Review findings published in the Archives of Internal Medicine challenge the notion that women with acute coronary syndrome are more likely to present with "atypical" symptoms. |
|
|
| 6. |
'Breakthrough' in HIV-linked lipodystrophy therapy
(Friday, December 07, 2007 - N Engl J Med 2007; 357: 2359-2370)
A synthetic human growth hormone-releasing factor has significant beneficial effects on lipid profiles and visceral obesity in patients with HIV-associated lipodystrophy, results from a phase III tria... |
|
|
| 7. |
'Cautious hope' that statins may help treat MS
(Friday, May 14, 2004 - JAMA 2004; 291: 2243-2252)
Study findings published in the latest issue of the journal The Lancet suggest that cholesterol-lowering statins could provide an effective treatment for multiple sclerosis. |
|
|
| 8. |
'Class effect' may underlie statins' survival benefits in HF patients
(Thursday, February 07, 2008 - Am Heart J 2008; 155: 316-323)
Observational data indicate that statins have a "class effect" in the prevention of mortality in patients with heart failure, which the researchers believe may relate to the agents' pleiotropic effect... |
|
|
| 9. |
'Delayed' approach to vascular risk intervention challenged
(Thursday, July 19, 2007 - Am J Cardiol 2007; 100: 217–221)
The vulnerability of elderly people to cardiovascular events is explained by the length of their exposure to vascular risk factors, say researchers who call for early preventive intervention in high-r... |
|
|
| 10. |
'Dominant vascular dysfunction pathway' reported
(Thursday, December 16, 2004 - Arterioscler Thromb Vasc Biol 2004; 24: 2302-2306)
The chlorinated fatty aldehyde 2-chlorohexadecanal attenuates the expression of endothelial nitric oxide synthase, as part of what scientists say could be the dominant pathway contributing to vascular... |
|
|
| 11. |
'Enigmatic' PCSK9 gene has large effects on LDL levels
(Friday, January 21, 2005 - Nat Genet 2005; 37: 161-165)
Findings published in an early online edition of the journal Nature Genetics show that common sequence variations in the PCSK9 gene can have large effects on plasma cholesterol levels. |
|
|
| 12. |
'Enormous' variation in European statin use revealed
(Monday, February 16, 2004 - Br Med J 2004; 328: 385-386)
Statin use in Europe varied greatly between countries in 2000, and increased rapidly over the period 1997 to 2002, study findings reveal. |
|
|
| 13. |
'Fat but fit' still need to lose weight
(Monday, October 16, 2006 - Am J Cardiol 2006; Advance online publication )
People who are overweight but have a good level of fitness still risk developing cardiovascular disease, research shows. |
|
|
| 14. |
'Fatty liver' determines severity of dyslipidemia
(Friday, August 04, 2006 - Diabetes Care 2006; 29: 1845-1850)
US and Canadian study results demonstrate that hepatic steatosis, or "fatty liver" disorder, may predict the severity of dyslipidemia in patients with Type 2 diabetes. |
|
|
| 15. |
'Gray-zone' BNP tied to heart failure prognosis
(Thursday, June 01, 2006 - Am Heart J 2006; 35: 1006–1011 )
Patients with established heart failure and B-type natriuretic peptide levels in the "gray zone" have better outcomes than those with higher levels, even if their disease severity is perceived as iden... |
|
|
| 16. |
'Hybrid' surgical, percutaneous coronary intervention shows promise
(Tuesday, April 01, 2008 - Am Heart J 2008; 155: 661-667)
A "hybrid" approach of simultaneous surgical and percutaneous coronary artery intervention revascularization offers acceptable clinical outcomes, without increasing bleeding risk, researchers say. |
|
|
| 17. |
'Hypertriglyceridemic waist' best CVD risk indicator
(Thursday, April 21, 2005 - Circulation 2005; 111: 1883-1890)
Researchers have lauded waist measurement combined with triglyceride concentration analysis as "the best indicator of cardiovascular disease risk in postmenopausal women." |
|
|
| 18. |
'Hypertriglyceridemic waist' identifies CAD risk
(Monday, December 11, 2006 - Am J Cardiol 2006; Advance online publication )
Scientists have acknowledged that the "hypertriglyceridemic waist" phenotype is a cheap and simple way to identify glucose intolerant or diabetic patients at high risk of coronary artery disease. |
|
|
| 19. |
'Insufficient' evidence for routine dyslipidemia screening in childhood
(Wednesday, July 04, 2007 - Pediatrics 2007; 120: e189–e214)
The US Preventive Services Task Force has concluded that there is insufficient evidence to support or refute routine screening of children and young adults for lipid disorders. |
|
|
| 20. |
'Intensified' diabetic hypercholesterolemia treatment recommended
(Monday, March 07, 2005 - Diab Care 2005; 28: 521-526)
Control of hypercholesterolemia and hypertension in individuals with Type 1 diabetes has not improved in the last decade and remains "extremely low", say the authors of a review of treatment trends in... |
|
|
| 21. |
'Late catch-up' in restenosis with drug eluting stent suggested
(Thursday, December 28, 2006 - J Am Coll Cardiol 2006; 48: 2432-2439)
Latest study findings suggest that the benefit of paclitaxel-eluting stents in terms of reducing restenosis following percutaneous coronary intervention may only be temporary. |
|
|
| 22. |
'Light' as damaging as regular cigarettes to coronary blood flow
(Tuesday, May 15, 2007 - Heart 2007; Advance online publication)
Smoking low-tar, low-nicotine cigarettes impairs coronary flow velocity reserve as severely as smoking regular cigarettes, Turkish researchers report. |
|
|
| 23. |
'Limited' evidence for statin effects on cognitive function
(Tuesday, December 21, 2004 - Am J Med 2004; 117: 823-829)
Study findings published in the American Journal of Medicine provide "partial" support for minor declines in cognitive functioning with statin use. |
|
|
| 24. |
'Lipid triad' drives diabetes atherosclerosis link
(Monday, January 10, 2005 - Diabetes Care 2005; 28: 108-114)
Low levels of high-density lipoprotein cholesterol, high triglyceride concentrations, and a pattern of small dense low-density lipoprotein cholesterol forms a 'lipid triad' that drives the atheroscler... |
|
|
| 25. |
'Meat-adaptive' genes involving lipid metabolism influenced human evolution
(Monday, March 29, 2004 - Q Rev Bio 2004; 79: 3-49)
The adaptive selection of meat-tolerant genes during human evolution offset high cholesterol and chronic diseases associated with eating meat, researchers propose. |
|
|
|
|
|
| Go
to Page :
Next >> |